Use of Bordetella Bronchiseptica and Bordetella Pertussis As Live Vaccines and Vectors for Heterologous Antigens

Overview

Journal FEMS Immunol Med Microbiol

Specialties Allergy & Immunology
Infectious Diseases
Microbiology

Date 2003 Jul 2

PMID 12832115

Citations 14

Authors

Andrew Stevenson

Mark Roberts

Affiliations

Soon will be listed here.

Abstract

Bordetella pertussis and Bordetella bronchiseptica are respiratory pathogens of humans and animals respectively. Unlike many bacteria, they are able to efficiently colonise healthy ciliated respiratory mucosa. This characteristic of Bordetella spp. can potentially be exploited to develop efficient live vaccines and vectors for delivery of heterologous antigens to the respiratory tract. Here we review the progress in this area.

Citing Articles

Is Lactococcus lactis a Suitable Candidate for Use as a Vaccine Delivery System Against Helicobacter pylori?.

Haghighi F, Farsiani H Curr Microbiol. 2024; 82(1):30.

PMID: 39643816 DOI: 10.1007/s00284-024-03994-1.

The Immunomodulatory Effects and Applications of Probiotic Lactiplantibacillus plantarum in Vaccine Development.

He G, Long H, He J, Zhu C Probiotics Antimicrob Proteins. 2024; 16(6):2229-2250.

PMID: 39101975 DOI: 10.1007/s12602-024-10338-9.

Differential microbial composition in parasitic vs. questing ticks based on 16S next-generation sequencing.

Zhang L, Han J, Zhou Q, He Z, Sun S, Li R Front Microbiol. 2024; 14:1264939.

PMID: 38192286 PMC: 10773790. DOI: 10.3389/fmicb.2023.1264939.

: A Suitable Candidate for the Construction of Novel Bioengineered Probiotic Strains for Targeted Pathogen Control.

Mathipa-Mdakane M, Thantsha M Foods. 2022; 11(6).

PMID: 35327208 PMC: 8947445. DOI: 10.3390/foods11060785.

[Use of lactic acid bacteria as mucosal vaccines].

Bermudez-Humaran L, Langella P Rev Francoph Lab. 2020; 2009(417):79-89.

PMID: 32518601 PMC: 7270964. DOI: 10.1016/S1773-035X(09)70312-0.